CompletedNot Applicable

RCT of Pulp Capping Over Carious Exposure in Adults

Lithuania, Norway80 participantsStarted 2010-10-18

Plain-language summary

This multicentre study was a randomized, controlled, parallel, patient-blinded, two-arm superiority trial with a 1:1 allocation ratio that followed the CONSORT guidelines.The aim of this study was to investigate whether MTA is more effective than a conventional calcium hydroxide liner (Dycal®) as a direct pulp capping material in mature molar teeth with a carious pulpal exposure.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Age 18-55 years * 1st and 2nd permanent molars * Proximal caries to inner 1/3 of dentin (bite-wing) * Apex closed, no periapical changes (apical radiograph) * No periodontal pockets deeper than 4mm * Medical history non-contributory (incl.pregnancy) * No medication (no antibiotics during last month) * No signs or symptoms more severe than reversible pulpitis * Positive response to electrical pulp test(EPT) or cold test * Written consent Inclusion requires compliance with all the criteria listed Exclusion criteria: * During the treatment there will be no pulpal exposure * The bleeding of the exposed pulp cannot be controled in 10 minutes

What they're measuring

Survival of Capped Pulps

Timeframe: 44 month

Trial details

NCT IDNCT01224925

SponsorUniversity of Tromso

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12-10

Results submitted2017-01-24

View on ClinicalTrials.gov More Carious Exposure trials